Atlas Trials

Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)

Clinical trial NCT00211354 · WITHDRAWN

Trial details

NCT number
NCT00211354
Sponsor
Manhattan Eye, Ear & Throat Hospital
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Retinal Vein Occlusion
Start date
2002-03-01
Primary completion
2007-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.